News | October 09, 2022
BioMarin simplifies organizational structure to increase efficiency
The reduction in force will result in financial savings of approximately $50 million annually beginning in 2023
The reduction in force will result in financial savings of approximately $50 million annually beginning in 2023
This clinical study will inform operational logistics and use of AV7909 should an anthrax emergency occur.
Brivaracetam is indicated for the treatment of partial-onset seizures in patients 4 years of age and older.
This win is on the back of a prestigious order from Reliance Life Sciences
Construction is now underway with the facility scheduled to be operational by 2025
Mandaviya felicitated voluntary blood donors and states/UTs that have done exemplary work
The booster vaccination trial is still ongoing and further data will provide more information around safety and efficacy.
Ours is a story of India’s resilient public health system and of everyone working together as team India to battle the pandemic
In the next six months, the program aims to screen 4,000 women from underprivileged communities in and around Mathura
Subscribe To Our Newsletter & Stay Updated
